Center for Immunity, Inflammation and Regeneration Medicine, Division of Nephrology, University of Virginia, Charlottesville, VA.
Center for Immunity, Inflammation and Regeneration Medicine, Division of Nephrology, University of Virginia, Charlottesville, VA.
Semin Nephrol. 2019 Jan;39(1):76-84. doi: 10.1016/j.semnephrol.2018.10.006.
Iron is required for key aspects of cellular physiology including mitochondrial function and DNA synthesis and repair. However, free iron is an aberration because of its ability to donate electrons, reduce oxygen, and generate reactive oxygen species. Iron-mediated cell injury or ferroptosis is a central player in the pathogenesis of acute kidney injury. There are several homeostatic proteins and pathways that maintain critical balance in iron homeostasis to allow iron's biologic functions yet avoid ferroptosis. Hepcidin serves as the master regulator of iron homeostasis through its ability to regulate ferroportin-mediated iron export and intracellular H-ferritin levels. Hepcidin is a protective molecule in acute kidney injury. Drugs targeting hepcidin, H-ferritin, and ferroptosis pathways hold great promise to prevent or treat kidney injury. In this review we discuss iron homeostasis under physiological and pathologic conditions and highlight its importance in acute kidney injury.
铁是细胞生理的关键方面所必需的,包括线粒体功能和 DNA 合成和修复。然而,由于铁能够提供电子、还原氧气并产生活性氧物种,因此游离铁是一种异常现象。铁介导的细胞损伤或铁死亡是急性肾损伤发病机制中的主要参与者。有几种体内平衡蛋白和途径可以维持铁动态平衡,使铁发挥生物学功能,同时避免铁死亡。hepcidin 通过调节 ferroportin 介导的铁输出和细胞内 H 铁蛋白水平,充当铁动态平衡的主调节剂。hepcidin 是急性肾损伤的保护分子。针对 hepcidin、H 铁蛋白和铁死亡途径的药物具有预防或治疗肾损伤的巨大潜力。在这篇综述中,我们讨论了生理和病理条件下的铁动态平衡,并强调了其在急性肾损伤中的重要性。